Fiduciary Alliance’s Genocea Biosciences, Inc. GNCA Stock Holding History

Fiduciary Alliance’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	–	–	487
2025 Q1	$0	Hold	10,000	–	–	﹤0.01%	406
2024 Q4	$0	Buy	+10,000	New	–	﹤0.01%	368

Fiduciary Alliance's GNCA Position: Q2 2025 in Review

Fiduciary Alliance sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2025, closing a stake of 10,000 shares.

Fiduciary Alliance first reported a position in GNCA in Q4 2024 and held it in 2 quarters. The position peaked at $0 in Q1 2025. 0 funds tracked by Wall St. Rank hold GNCA as of Q2 2025.

Fiduciary Alliance reported no remaining Genocea Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
Fiduciary Alliance sold 10,000 Genocea Biosciences, Inc. shares in Q2 2025.
Fiduciary Alliance first reported a position in Genocea Biosciences, Inc. in Q4 2024 and held it in 2 quarters.
Fiduciary Alliance's Genocea Biosciences, Inc. position peaked at $0 in Q1 2025.
0 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2025.

Based on Fiduciary Alliance's 13F filing for Q2 2025, filed 9 Jul 2025.